
    
      The objective of the project is to perform a post marketing clinical study to confirm safety
      and clinical effectiveness of WET® gel in the treatment of nasal dryness.

      This investigation will be carried out following the CE marking of the WET® gel device and is
      mainly intended to answer questions relating to clinical safety or performance (i.e. residual
      risks) of the device when used in accordance whit its approved labelling.

      The study is also aimed at defining the optimal dose regimen of WET® gel.
    
  